hiv-1

Documents about hiv-1

• Enhancement by Poly-ICLC During HIV-1 Infection#28307ClinicalTrials.gov
• Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)#1174226ClinicalTrials.gov
• A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication#1128117ClinicalTrials.gov
• Prevalence of HTLV-1 and HTLV-2 infection among transgender women in Brazil: A multicenter study#437348PLOS
• Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals#833793ClinicalTrials.gov
• Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid#840917ClinicalTrials.gov
• Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects#1100957ClinicalTrials.gov
• Safety Study of Elvucitabine in HIV-1 Subjects#906135ClinicalTrials.gov
• immature HIV-1#361653CaltechDATA
• mature HIV-1#1056775CaltechDATA
• A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects#855639ClinicalTrials.gov
• A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)#1047917ClinicalTrials.gov
• Towards HIV Functional Cure#906822ClinicalTrials.gov
• Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation#829492ClinicalTrials.gov
• Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection#1322274ClinicalTrials.gov
• HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study#1127792ClinicalTrials.gov
• The Detection of Drug-Resistant HIV-1 in Taiwan#835033ClinicalTrials.gov
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles#1312891HAL (France)
• Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1#1279311ClinicalTrials.gov
• Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF#891507ClinicalTrials.gov
• CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS#864012ClinicalTrials.gov
• TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1#1320823ClinicalTrials.gov
• An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons#887700ClinicalTrials.gov
• Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis#905047ClinicalTrials.gov
• Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection#981641ClinicalTrials.gov
• A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers#230477ClinicalTrials.gov
• The landscape of ifn/isg signaling in hiv-1-infected macrophages and its possible role in the hiv-1 latency#948296Repositorio de Universidad Autónoma de Chile.
• Study of Novel Antiretrovirals in Participants With HIV-1#871442ClinicalTrials.gov
• Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients#1228612ClinicalTrials.gov
• Novel Interventions in HIV-1 Infection#804916ClinicalTrials.gov
• Quantification of Antisense HIV RNA in Patients#1229222ClinicalTrials.gov
• Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults#1260697ClinicalTrials.gov
• Phase 1 Safety Study of Two Experimental HIV Vaccines#806647ClinicalTrials.gov
• HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults#1245365ClinicalTrials.gov
• HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia#831398ClinicalTrials.gov
• Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon#1172827ClinicalTrials.gov
• Purified HIV-1 capsid-Ruby#1161220CaltechDATA
• Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral Therapy#866522ClinicalTrials.gov
• A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons#1196597ClinicalTrials.gov
• An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects#874580ClinicalTrials.gov
• Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women#1111730ClinicalTrials.gov
• 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults#394599ClinicalTrials.gov
• Exploration of HIV Reservoirs#837563ClinicalTrials.gov
• Immune Response to Hepatitis C Virus#914292ClinicalTrials.gov
• Baricitinib Curative Repression of HIV-1#1127009ClinicalTrials.gov
• Relationship Between HIV-1 Subtype and ARV Response#1127305ClinicalTrials.gov
• Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults#840369ClinicalTrials.gov
• Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART#993475ClinicalTrials.gov
• Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial#993423ClinicalTrials.gov